ArticleThe Journal of small animal practice2026
Cumulative gonadal hormone exposure is nonlinearly associated with risk of canine cranial cruciate ligament disease: a generalised additive model analysis of 20,590 dogs (1988-2023).
Article in The Journal of small animal practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
objectivesTo investigate the association between cumulative gonadal hormone exposure and the risk of cranial cruciate ligament disease (CrCLD) in dogs. MATERIALS AND
methodsSecondary analysis of retrospective cohort data of 20,590 dogs (9845 female, 10,745 male) investigating the association between age at gonadectomy and various health outcomes in dogs was conducted. Cumulative gonadal hormone exposure was defined as the continuous independent variable. The occurrence of CrCLD was binarily defined as the outcome measure. Generalised additive models were used to assess the relationship between hormone exposure and risk of CrCLD, adjusted for potential confounders.
resultsThe prevalence of CrCLD was 245 of 9845 (2.49%) in females and 203 of 10,745 (1.89%) in males. The risk of CrCLD was nonlinearly associated with cumulative gonadal hormone exposure in both sexes. The risk of CrCLD was greatest in dogs with the least gonadal hormone exposure, sharply decreasing to minima at 1054 days for females and 805 days for males. CLINICAL SIGNIFICANCE: Risk of CrCLD is nonlinearly associated with age at gonadectomy in dogs. Early gonadectomy may be preliminarily defined as that before 2.9 and 2.2 years in female and male dogs, respectively, in the context of CrCLD risk.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.